Device Trial Radar · NCT03054064
Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA
Last checked: Nov 20, 2026Latest source record: Apr 7, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
48
Actual
Start
Feb 21, 2017
Primary completion
Dec 28, 2017
Study completion Jan 17, 2018
Sponsor
- Lead sponsor
- Parker Hannifin CorporationNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Shepherd Center, Atlanta GA; Cedars-Sinai Medical Center; Sheltering Arms Physical Rehabilitation Hospitals; Shirley Ryan AbilityLab; Kessler Foundation; St. Charles Hospital; TIRR Memorial Hermann; Rusk Rehabilitation
- First posted
- Feb 15, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and effectiveness of the Indego exoskeleton as a gait training tool for individuals with hemiplegia due to Cerebrovascular Accident (CVA).
Conditions
- Cerebrovascular Accident (CVA)
- Stroke
- Hemiplegia
Interventions
Indego ExoskeletonDevice
Six study sessions including five Indego training sessions over two weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety of Individuals With Hemiplegia Due to CVA Using the Indego Measured Through Reported Subject Adverse Events and Serious Adverse EventsTime frame: 2 weeks
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Cedars-Sinai Health System
Los Angeles, California
6 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.